FDA Inspection 1153385 — Wilmington Reproductive Laboratories
The FDA completed an inspection of Wilmington Reproductive Laboratories on Aug 26, 2021 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 26, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Wilmington, NC (United States)